Celularity Inc. (CELUW)

Market Cap	105.16M
Revenue (ttm)	44.59M
Net Income (ttm)	-73.67M
Shares Out	26.69M
EPS (ttm)	-3.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,600
Open	0.0600
Previous Close	0.0600
Day's Range	0.0600 - 0.0600
52-Week Range	0.0075 - 0.7511
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 31, 2025

About CELUW

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating facioscap...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 123
• Stock Exchange: NASDAQ
• Ticker Symbol: CELUW
• Website: https://www.celularity.com